Clínica Baviera, S.A. (BME:CBAV)
Spain · Delayed Price · Currency is EUR 59.40
+1.60 (2.77%)
Jun 5, 2026, 5:35 PM CET
Clínica Baviera Market Cap
Clínica Baviera has a market cap or net worth of €951.5 million as of June 5, 2026. Its market cap has increased by 53.61% in one year.
Market Cap
951.50M
Enterprise Value
971.31M
Revenue
304.91M
Ranking
n/a
PE Ratio
22.61
Stock Price
€59.40
Market Cap Chart
Since April 10, 2007, Clínica Baviera's market cap has increased from 369.53M to 951.50M, an increase of 157.49%. That is a compound annual growth rate of 5.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 951.50M | 19.57% |
| Dec 31, 2025 | 795.80M | 59.55% |
| Dec 31, 2024 | 498.78M | 33.02% |
| Dec 29, 2023 | 374.97M | 31.81% |
| Dec 30, 2022 | 284.48M | -17.68% |
| Dec 30, 2021 | 345.60M | 50.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.55B |
| Laboratorios Farmaceuticos Rovi | 3.01B |
| Almirall | 2.41B |
| Pharma Mar | 1.67B |
| Faes Farma | 1.42B |
| Oryzon Genomics | 232.07M |
| Prim, S.A. | 225.43M |
| Laboratorio Reig Jofre | 220.63M |